ARH-77 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The ARH-77 cell line is a human cell line derived from the peripheral blood of a 33-year-old female patient with plasma cell leukemia, a type of cancer that affects plasma cells in the bone marrow. ARH-77 cells are characterized by their B lymphoblastoid phenotype, which makes them particularly useful for studying B-cell maturation and function as well as plasma cell leukemia pathology. This cell line is also frequently used in research related to Epstein-Barr virus (EBV), as it is EBV-transformed. |
|---|---|
| Organism | Human |
| Tissue | Blood |
| Disease | Plasma Cell Leukemia |
| Applications | 3D cell culture, Immune system disorder research, Immunology |
| Synonyms | ARH 77, ARH77 |
Characteristics
| Age | 33 years |
|---|---|
| Gender | Female |
| Ethnicity | European |
| Morphology | Lymphoblast |
| Cell type | B lymphoblast |
| Growth properties | Suspension |
Regulatory Data
| Citation | ARH-77 (Cytion catalog number 300306) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1072 |
Biomolecular Data
| Antigen expression | CD11a +, CD19 +, CD20 +, CD28 +, CD38 -, CD49e, +CD3 -, CD10 -, CD13 -, CD19 +, CD20 +, CD34 -, CD37 +, CD71 +, cyCD79 +, CD80 +, CD138 -, HLA-DR +, sm/cyIgG +, sm/cyIgM -, sm/cykappa +, sm/cylambda - |
|---|---|
| Viruses | EBV + (transformant), HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV |
| Karyotype | Human near diploid karyotype with 8% polyploidy - 46(44-48)<2n>xx, +9, del(1)(q23), add(2)(q21), add(3)(p11), der(3)t(2,3)(q23,q26), del(6)(p21), der(9)t(9,17)(q10,q10) - sideline with der(x)t(x,1)(q23,p32), del(16)(p13.2) and unresolved der(3) and der(9)hsr markers - no IGH translocations detected |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300306-180925 | Certificate of Analysis | 05. Dec. 2025 | 300306 |
| 300306-240823 | Certificate of Analysis | 23. May. 2025 | 300306 |